SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: I. Luttichuys who wrote (164)12/5/1996 6:27:00 PM
From: Julie Suk   of 1762
 
Hello Bennet and Rick

I fully agree with your assessment of Idec. I can not predict the future however listen to the past: we initially bought Idec at $6 a year and a half ago and sold it at $16, then bought it back at $18 and sold it at $30. Recently I bought it at $18. I was very fortunate to catch the upcycles. Do you know that the phase III trials for C2B8 are positive? I called Idec's investor relations and she said they would announce their results in Florida on Monday, Dec 9 at 11:00 A.M. EST. If you know anything definitive before then, post it.

Julie
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext